AzTrials
AzTrials

Frailty SyndromeSWIMFRAILNCT03955302

Ultrasound Assessment of a Physical Exercise in The Water in a Frail Population

A study testing Exercise in people with Frailty Syndrome, run by University of Valencia at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It is an experimental, longitudinal prospective, controlled trial. The project will be developed in the General University Hospital of Valencia (CHGUV), and the University of Valencia. Patients will be recruited from a previous cohort. The patients of this cohort will be contacted and proposed to participate. Read more about this study

Who is it for?
Ages 65 to 95 years
Conditions the study is for
Frailty Syndrome
What is being tested?
Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteSpain
Study dates
1 Aug 2018to 31 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 95 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Age between 65 and 95 years, be physically inactive (<150 min physical activity a week), meet 1 or more criteria of frailty according to Linda Fried criteria, signature of informed consent.

Who cannot join

  • Institutionalized patients, life expectancy of less than 6 months for any reason, hospital admission in the last 3 months for any reason; major surgery in the last 6 months before the start of the study, oncological patient with active treatment with chemotherapy or radiotherapy; neurological or musculoskeletal pathology that contraindicates physical activity in water; severe disability (score below 15 points on the Barthel scale); severe cardiovascular disease, psychotic disorder or severe cognitive impairment.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital General Universitario de Valencia

    Valencia, 46014

Other trials in Spain

About this study

Official title: Ultrasound Assessment of Muscle Architecture Before and After the Implementation of a Physical Exercise Regime in the Water in a Frail Elderly Population

It is an experimental, longitudinal prospective, controlled trial. The project will be developed in the General University Hospital of Valencia (CHGUV), and the University of Valencia.

Patients will be recruited from a previous cohort. The patients of this cohort will be contacted and proposed to participate. Those patients who accept, will be divided into the following experimental groups:

Read more
  • Group 1: Patients in this group will perform the water exercise protocol, 3 times a week, for 12 weeks.
  • Group 2: Patients in this group will not perform any type of exercise during the 12 weeks of the treatment.

Variables related to muscular quality by ultrasound, frailty, physical function, independence in the activities of daily life, balance, cognitive function, quality of life and sleep, the social sphere will be evaluated, and the intensity of pain and fatigue, before and after12 weeks of intervention.

Read the detailed description

OBJECTIVE To evaluate changes in muscle architecture by ultrasound, before and after an intervention with physical exercise directed in water in frail individuals; and determine the correlation of the image findings with the changes detected in their morbidity, functionality and quality of life.

SAMPLE

The sample will be composed of at least 40 frail men and women, according to Frail Phenotype criteria. Patients will be recruited from a previous cohort. For the assessment of frail, Linda Fried's criteria will be used: unintentional weight loss, feeling of general exhaustion, slow gait, low level of physical activity or muscular weakness. A point will be assigned to each positive criterion. A final score formed by the sum of the five criteria. According to this score, subjects will be classified as follows:

  • Non-frail: 0 points
  • Pre-frail: 1 or 2 points
  • Frail: 3 or more points

STUDY DESIGN It is an experimental, prospective, controlled study. Patients will be recruited from a previous cohort performed at the General University Hospital of Valencia (CHGUV). This study was entitled "Muscular architecture study by ultrasound for the diagnosis of frail with correlation of clinical, physical and biochemical markers". The patients of this cohort will be contacted by telephone, where they will be proposed to participate in the present study. Patients that accept will be ask to undergo a muscle ultrasound. At that time those who meet the inclusion criteria and none of the exclusion criteria, will be presented with the option of participating in the targeted exercise intervention. The subjects will be divided into Group 1 (Exercise) or Group 2 (Control). Those who agree to participate will be given the informed consent, offering them the appropriate time to read it and resolve doubts about it.

All eligible subjects will be informed of the objectives of the study and will be asked to collaborate in it. Before the ultrasound examination, the patients will be explained that the procedure is experimental and what is the purpose of the study. Being a study with intervention, the need to maintain maximum adherence to the physical exercise regime during the 12 weeks, as well as the need to perform all assessments both before and after the intervention.

Variables related to the diagnosis of muscular quality by ultrasound, frailty condition, morbidity, physical function, independence in the activities of daily life, balance, cognitive function, quality of life and sleep, the social sphere will be evaluated, and the intensity of pain and fatigue, before and after the 12 weeks of intervention.

The muscular ultrasound will be performed in the Radiology Department of the Hospital. At the conclusion of the ultrasound, a muscle strength measurement will be performed with a dynamometer and patients will fill out a questionnaire of epidemiological data, medical history, comorbidities and, criteria of frailty. A second appointment will be scheduled to make a blood extraction for biochemical analysis. After concluding the intervention, patients will be called again to perform a follow-up ultrasound, questionnaires, physical function assessment and biochemical analysis.

INTERVENTION For the exercise in the water (aqua aerobics), there will be an expert physiotherapist in the field of hydrotherapy that will guide the exercises in controlled sessions of approximately 45 minutes. Exercises of joint mobility, balance, strength and coordination with / without aquatic material (tables, cork anklets, long corks, cork dumbbells, pull-boy, and inflatable collars, among others) will be included. At all times, qualified health personnel will monitor any symptom or sign that advises the removal of the subject of the study (maintained dizziness, hypertension or uncontrolled hypotension, chest pain, muscular or tendon injuries, etc).

MUSCULAR ULTRASOUND Studies of muscle architecture through ultrasound show a non-invasive method to detect isometric contraction of individual muscles. In addition to being non-invasive, accessible and economical, it allows the dynamic exploration of the muscle under study.

The ultrasound allows, on the one hand, assessment of the quantitative parameters at rest and contraction, measuring muscle thickness, anatomical and physiological area puncture angle and fascicular length. On the other hand, muscle intensity echo will be assessed as a qualitative parameter. The muscle architecture of the anterior compartment of the leg will be evaluated by ultrasound in B mode, obtaining transverse and longitudinal images with a linear transducer (6-15 MHz). The measurements of the muscle ultrasound will be made three times and the average of said measurements will be used in the data analysis. The images made during the scan will be stored in the hospital picture archiving and communication system (PACS).

DATA COLLECTION The first section of the questionnaire will include questions about general epidemiological data and details of the patient's medical history. The following parameters will be recorded: age, gender, marital status (single, married or widowed) and social situation (spouse, alone or with children). Among the anthropometric parameters, the height and the weighed of the participants will be measured to perform the calculations of the patient's body mass index. The presence or absence of hypertension, hyperlipidemia, diabetes mellitus, heart failure according to Framingham criteria, ischemic heart disease, presence of previous stroke, chronic obstructive disease, smoker (yes, no or ex-smoker) will be included in the patient's clinical history. Visual problems, hearing problems, Parkinson's disease, depression, previous cancer, kidney failure, arthritis, osteoporosis and number of recent fractures will also be assessed. In addition, an index of comorbidities will be carried out according to the Charlson index using an online calculator and number of falls in the previous 6 months. And finally, the number of visits to the primary care physician, emergencies and hospital admissions in the last 6 months.

ASSESSMENT OF PHYSICAL FUNCTION Various tests will be carried out to assess the physical function. Individuals will be asked the following requirements: comfortable clothing and footwear, light food (no fasting prior to the test), no intense exercise in the previous 2 hours, no present conditions that limit walking, and that may interfere with the interpretation of the test, such as injuries to the lower extremities or respect the schedules of the medication that the patient takes regularly. All tests will be conducted by a qualified physiotherapist. The test are 6-minute walk test, Borg Scale, Short Physical Performance Battery (SPPB), and "timed up and go" test. Likewise, different scales will be carried out to assess the independence, and activities of daily life, assessment of balance or risk of falls. For the assessment of cognitive function (Hospital Anxiety and Depression Scale (HADS), for the assessment of quality of life (Older People Quality of Life (OPQOL), and sleep (Pittsburgh Sleep Quality Index), for the assessment of the social sphere (Duke social support), and for the assessment of pain intensity (McGill Questionnaire) and fatigue (fatigue severity scale).

BIOCHEMICAL BIOMARKERS A blood extraction will be requested by the subjects general practitioners. A blood sample will be taken from the CHGUV clinical analysis department before and after the intervention. The biomarkers will be measured in a blood sample drawn between 8:00 a.m. and 10:30 a.m. after fasting for at least 8 hours and your usual procedure will be done with the protocols already established in the bio clinical analysis department.

STATISTICAL ANALYSIS The descriptive data are presented with the mean ± standard deviation (SD) with the distribution of the data verified by the Shapiro-Wilk and / or Kolmogorov-Smirnov normality test. To evaluate differences in physical characteristics and study variables, t-Student was used for parametric and Mann-Whitney variables for non-parametric variables. The evaluation of the different study variables according to the stages of fragility and control group will be determined by means of analysis of variance (ANOVA) for the parametric variables (followed by the Bonferroni post hoc test) and for the non-parametric Kruskal-Wallis test. To assess the sonographic changes after the intervention of the patients with directed exercise, the T-student test will be used for paired data. The correlations will be made with the Pearson coefficient for parametric data and the Spearman range for non-parametric data. The correlations were considered weak for the correlation coefficient of ± 0.01 to 0.35, moderate for ± 0.36 to 0.67 and strong for ± 0.68 to 1.00. To compare the reliability between sonographer and evaluators of functional tests; we perform the intraclass correlation coefficient (ICC) and the Bland-Altman agreement limits of 95%. The ICC values were classified as poor for values ≤0.20, just for 0.21-0.40, moderate for 0.41-0.60, good for 0.61-0.80 and very good for 0.81-1.00. To assess the accuracy of muscle ultrasound, the area under the receiver operating characteristic (ROC) curve or curves will be determined. The statistical significance will be defined a priori as P <0.05. All statistical analyses will be performed with Statistical Package for the Social Sciences (SPSS) version 24.0 for Windows.

Being tested
Exercise
Keywords
Frailty, Muscle Architecture, Ultrasound, Exercise Regimen, Aqua-Aerobics
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseBehavioural

    There will be an intervention for 12 weeks. For exercises in the water, there will be an expert physiotherapist in the field of hydrotherapy that will guide the exercises in controlled sessions of approximately 45 minutes. Exercises of joint mobility, balance, strength and coordination with / without aquatic material will be included. At all times, qualified health personnel will monitor any symptom or sign that advises the removal of the subject of the study.

Study groups in NCT03955302
Study groupRoleWhat they receive
ExerciseExperimentalPatients in this group will perform the water exercise protocol, 3 times a week, for 12 weeks.
Receives: Behavioral: Exercise
ControlNo interventionPatients in this group will not perform any type of exercise during the 12 weeks of the treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle Architecture Improvement

    Muscle measurement with ultrasound before and after the intervention

    Measured: 14 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2019
  2. Study start1 Aug 2018
  3. Primary completion31 Dec 2019
  4. Study completion31 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03955302
Sponsor's protocol ID
1557856842051
Acronym
SWIMFRAIL
Status last verified
May 2019
First submitted
16 May 2019
Last updated
18 May 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Abe T, Loenneke JP, Thiebaud RS, Fukunaga T. Age-related site-specific muscle wasting of upper and lower extremities and trunk in Japanese men and women. Age (Dordr). 2014 Apr;36(2):813-21. doi: 10.1007/s11357-013-9600-5. Epub 2013 Nov 17.

    PubMed 24243442
  • Arts IM, Pillen S, Overeem S, Schelhaas HJ, Zwarts MJ. Rise and fall of skeletal muscle size over the entire life span. J Am Geriatr Soc. 2007 Jul;55(7):1150-2. doi: 10.1111/j.1532-5415.2007.01228.x. No abstract available.

    PubMed 17608902
  • Arts IM, Pillen S, Schelhaas HJ, Overeem S, Zwarts MJ. Normal values for quantitative muscle ultrasonography in adults. Muscle Nerve. 2010 Jan;41(1):32-41. doi: 10.1002/mus.21458.

    PubMed 19722256
  • Bouillon K, Kivimaki M, Hamer M, Sabia S, Fransson EI, Singh-Manoux A, Gale CR, Batty GD. Measures of frailty in population-based studies: an overview. BMC Geriatr. 2013 Jun 21;13:64. doi: 10.1186/1471-2318-13-64.

    PubMed 23786540
  • Bowling A. The Psychometric Properties of the Older People's Quality of Life Questionnaire, Compared with the CASP-19 and the WHOQOL-OLD. Curr Gerontol Geriatr Res. 2009;2009:298950. doi: 10.1155/2009/298950. Epub 2010 Feb 1.

    PubMed 20168974
  • Bressel E, Wing JE, Miller AI, Dolny DG. High-intensity interval training on an aquatic treadmill in adults with osteoarthritis: effect on pain, balance, function, and mobility. J Strength Cond Res. 2014 Aug;28(8):2088-96. doi: 10.1519/JSC.0000000000000258.

    PubMed 25057845
  • Cadore EL, Izquierdo M, Conceicao M, Radaelli R, Pinto RS, Baroni BM, Vaz MA, Alberton CL, Pinto SS, Cunha G, Bottaro M, Kruel LF. Echo intensity is associated with skeletal muscle power and cardiovascular performance in elderly men. Exp Gerontol. 2012 Jun;47(6):473-8. doi: 10.1016/j.exger.2012.04.002. Epub 2012 Apr 14.

    PubMed 22525196
  • Cesari M, Fielding RA, Pahor M, Goodpaster B, Hellerstein M, van Kan GA, Anker SD, Rutkove S, Vrijbloed JW, Isaac M, Rolland Y, M'rini C, Aubertin-Leheudre M, Cedarbaum JM, Zamboni M, Sieber CC, Laurent D, Evans WJ, Roubenoff R, Morley JE, Vellas B; International Working Group on Sarcopenia. Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle. 2012 Sep;3(3):181-90. doi: 10.1007/s13539-012-0078-2. Epub 2012 Aug 3.

    PubMed 22865205
  • Csapo R, Alegre LM. Effects of resistance training with moderate vs heavy loads on muscle mass and strength in the elderly: A meta-analysis. Scand J Med Sci Sports. 2016 Sep;26(9):995-1006. doi: 10.1111/sms.12536. Epub 2015 Aug 24.

    PubMed 26302881
  • Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008 Dec;61(12):1234-1240. doi: 10.1016/j.jclinepi.2008.01.006. Epub 2008 Jul 10.

    PubMed 18619805
  • Cho KH, Lee HJ, Lee WH. Intra- and inter-rater reliabilities of measurement of ultrasound imaging for muscle thickness and pennation angle of tibialis anterior muscle in stroke patients. Top Stroke Rehabil. 2017 Jul;24(5):368-373. doi: 10.1080/10749357.2017.1285745. Epub 2017 Feb 15.

    PubMed 28198659
  • Chumlea WC, Cesari M, Evans WJ, Ferrucci L, Fielding RA, Pahor M, Studenski S, Vellas B; International Working Group on Sarcopenia Task Force Members. Sarcopenia: designing phase IIB trials. J Nutr Health Aging. 2011 Jun;15(6):450-5. doi: 10.1007/s12603-011-0092-7.

    PubMed 21623466
  • Cooper C, Fielding R, Visser M, van Loon LJ, Rolland Y, Orwoll E, Reid K, Boonen S, Dere W, Epstein S, Mitlak B, Tsouderos Y, Sayer AA, Rizzoli R, Reginster JY, Kanis JA. Tools in the assessment of sarcopenia. Calcif Tissue Int. 2013 Sep;93(3):201-10. doi: 10.1007/s00223-013-9757-z. Epub 2013 Jul 11.

    PubMed 23842964
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.

    PubMed 20392703
  • D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med. 1993 Nov;32(5):382-7.

    PubMed 8295545

Questions about this trial

What is this clinical trial studying?

A study testing Exercise in people with Frailty Syndrome, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle Architecture Improvement (time frame: 14 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03955302, which also lists 39 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in